EurekAlert (press release) (WASHINGTON, November 18, 2014) - New evidence suggests that therapeutic plasma exchange and appropriate blood testing could help patients who...
In-PharmaTechnologist.com Heparin production may be moving back to Europe according to the EFCG, which cited the opening of Pharma Action's processing plant as an indication that API buyers value quality and compliance throughout the supply chain. and more »
Scientific American Clots are clumps of blood cells, platelets and proteins, and so it seemed logical to think that diluting, or thinning, the blood with heparin would...
Ubyssey Online Kizhakkedathu said that one to three percent of the global population uses heparin . It is not only used for the regular treatment of cardiovascular disease such as venous or arterial thromboembolism but also in most surgeries and all dialysis procedures.
MedPage Today Aripazine is a synthetic small molecule (D-arginine compound) that has broad activity against various old ( heparin , low-molecular-weight heparin ) and new oral anticoagulants (dabigatran [Pradaxa], rivaroxaban [Xarelto], apixaban [Eliquis], and edoxaban ...
